https://www.selleckchem.com/pr....oducts/darapladib-sb
05). The rate of POPF in the HR-PD group was 39%. Mortality was comparable between the two groups (3% vs 4%). Although general, cancer- and pancreas-specific QoL were comparable between the HR-PD and C-TP groups, endocrine and exocrine insufficiency occurred in all the C-TP patients, compared to only 13% and 63% of the HR-PD patients respectively, and C-TP patients had worse diabetes-specific QoL. C-TP may be considered rather than HR-PD only in few selected cases and after adequate counselling. C-TP may be considered rathe
Curtir
Comentario
Compartilhar
